While highly accurate, LC-HRMS is not part of routine clinical monitoring and is mostly used in research or drug development settings
Call to Action Patients considering GLP-1 or dual agonist therapy should consult licensed healthcare providers and verify coverage options before starting treatment
The programs include: Metabolic Intensive a program for the management of type 1 diabetes, type 2 diabetes, hypertension, comorbid obesity, and/or hyperlipidemia
Hurlemann R, Patin A, Onur OA, Cohen MX, Baumgartner T, Metzler S et al (2010)
Moreover, using probucol (500 mg/day, P.O for 6 months) for secondary prevention in patients with CHD lowered the incidence of the patients primary endpoint (cardiovascular disease death, hospitalization rate), which may be partly due to its strong antioxidant capacity [245]
Evidence suggests that it works via vasorelaxation